Caplin Point Laboratories Ltd vs Iol Chemicals Pharmaceuticals Ltd Stock Comparison
Caplin Point Laboratories Ltd vs Iol Chemicals Pharmaceuticals Ltd Stock Comparison
Last Updated on: May 03, 2026
Key Highlights
The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 1710 as of 30 Apr 15:30
. The P/E Ratio of Caplin Point Laboratories Ltd changed from 17.2 on March 2022 to 12.6 on March 2021 . This represents a CAGR of -6.03% over 5 yearsThe P/E Ratio of IOL Chemicals & Pharmaceuticals Ltd changed from 12.4 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 years The Market Cap of Caplin Point Laboratories Ltd changed from ₹ 5152 crore on March 2022 to ₹ 3057 crore on March 2021 . This represents a CAGR of -9.92% over 5 yearsThe Market Cap of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 2077 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 years The revenue of Caplin Point Laboratories Ltd for the Dec '25 is ₹ 576.45 crore as compare to the Sep '25 revenue of ₹ 564.43 crore. This represent the growth of 2.13% The revenue of IOL Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 585.68 crore as compare to the Sep '25 revenue of ₹ 574.41 crore. This represent the growth of 1.96% The ebitda of Caplin Point Laboratories Ltd for the Dec '25 is ₹ 223.35 crore as compare to the Sep '25 ebitda of ₹ 219.56 crore. This represent the growth of 1.73% The ebitda of IOL Chemicals & Pharmaceuticals Ltd for the Dec '25 is ₹ 51.36 crore as compare to the Sep '25 ebitda of ₹ 63.96 crore. This represent the decline of -19.7% The net profit of Caplin Point Laboratories Ltd changed from ₹ 124.92 crore to ₹ 165.86 crore over 7 quarters. This represents a CAGR of 17.58%
The net profit of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 29.97 crore to ₹ 20.58 crore over 7 quarters. This represents a CAGR of -19.33%
The Dividend Payout of Caplin Point Laboratories Ltd changed from 14.53 % on March 2021 to 13.43 % on March 2025 . This represents a CAGR of -1.56% over 5 yearsThe Dividend Payout of IOL Chemicals & Pharmaceuticals Ltd changed from 7.92 % on March 2021 to 23.25 % on March 2025 . This represents a CAGR of 24.03% over 5 years .
About Caplin Point Laboratories Ltd
Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990.
The Company is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections.
Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.
About IOL Chemicals & Pharmaceuticals Ltd
IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active Pharmaceutical
Ingredient (API) and specialty chemicals sectors.
Its extensive expertise in both API and specialty chemicals strengthens the business model and opens doors to diversified growth opportunities.
Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines.
It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories.
In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride.
FAQs for the comparison of Caplin Point Laboratories Ltd and IOL Chemicals & Pharmaceuticals Ltd
Which company has a larger market capitalization, Caplin Point Laboratories Ltd or IOL Chemicals & Pharmaceuticals Ltd?
Market cap of Caplin Point Laboratories Ltd is 13,002 Cr while Market cap of IOL Chemicals & Pharmaceuticals Ltd is 2,765 Cr
What are the key factors driving the stock performance of Caplin Point Laboratories Ltd and IOL Chemicals & Pharmaceuticals Ltd?
The stock performance of Caplin Point Laboratories Ltd and IOL Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Caplin Point Laboratories Ltd and IOL Chemicals & Pharmaceuticals Ltd?
As of May 3, 2026, the Caplin Point Laboratories Ltd stock price is INR ₹1710.6. On the other hand, IOL Chemicals & Pharmaceuticals Ltd stock price is INR ₹94.2.
How do dividend payouts of Caplin Point Laboratories Ltd and IOL Chemicals & Pharmaceuticals Ltd compare?
To compare the dividend payouts of Caplin Point Laboratories Ltd and IOL Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.